MaureenDMayesMD

Rheumatology • Houston, TX

Scleroderma & Related

Professor of Medicine, University Tex Houston

Join to view full profile

Dr. Mayes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Mayes' full profile

Already have an account?

Office
6431 Fannin St
MSB 5.270
Houston, TX 77030
Phone+1 713-500-6905

Fax+1 713-500-0580
Is this information wrong?

Education & Training

Cleveland Clinic FoundationFellowship, Rheumatology, 1980 - 1980
Cleveland Clinic FoundationResidency, Internal Medicine, 1978 - 1979
Cleveland Clinic FoundationResidency, Internal Medicine, 1977 - 1977
Eastern Virginia Medical SchoolClass of 1976

Certifications & Licensure

TX State Medical License 2002 - 2024
VA State Medical License 1977 - 2004
MI State Medical License 1985 - 2004
WV State Medical License 1981 - 1985
OH State Medical License 1977 - 1982
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2002-2014, 2017-2020
Top Doctors:SE Texas Castle Connolly, 2013
Super Doctor SuperDoctors.com
Fellow (FACR) American College of Rheumatology
Join now to see all

Clinical Trials

Scleroderma Registry Start of enrollment: 2000 Sep 01
Completed
Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma Start of enrollment: 2003 Oct 01
Completed
Phase 3
Scleroderma: Cyclophosphamide or Transplantation Start of enrollment: 2005 Jun 01
Completed
Phase 2, Phase 3
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients Start of enrollment: 2005 Feb 01
Completed
SCOT Scleroderma Treatment Alternative Registry (STAR Registry) Start of enrollment: 2005 Jun 01
Completed
Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
Completed
Phase 2
Scleroderma Treatment With Autologous Transplant (STAT) Study Start of enrollment: 2011 Sep 15
Active, not recruiting
Phase 2
Safety and Tolerability of Pirfenidone in Participants With Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD) (LOTUSS) Start of enrollment: 2013 Oct 01
Completed
Phase 2
Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER Start of enrollment: 2017 Apr 18
Terminated
Phase 3
Platform Clinical Study for Conquering Scleroderma Start of enrollment: 2024 Apr 01
Not yet recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

The association of resilience and positive mental health in systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) cohort cross-sectional study.
Marieke A Neyer, Richard S Henry, Marie-Eve Carrier, Linda Kwakkenbos, Gabrielle Virgili-Gervais, Robyn K Wojeck, Amanda Wurz, Amy Gietzen, Karen Gottesman, Geneviève ...> ;Journal of Psychosomatic Research. 2024 Apr 1
Factors associated with satisfaction with social roles and activities among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network (SPIN) ...
Tiffany Dal Santo, Danielle Rice, Marie-Eve Carrier, Gabrielle Virgili-Gervais, Brooke Levis, Linda Kwakkenbos, Susan J Bartlett, Amy Gietzen, Karen Gottesman, Genevie...> ;RMD Open. 2024 Feb 29
7 citations
A 24-Week, Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of Ziritaxestat in Early Diffuse Cutaneous Systemic Sclerosis.
Dinesh Khanna, Christopher P Denton, Daniel E Furst, Maureen D Mayes, Marco Matucci-Cerinic, Vanessa Smith, Dick de Vries, Paul Ford, Yasmina Bauer, Matthew J Randall,...> ;Arthritis & Rheumatology. 2023 Aug 1
Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis.
Robyn T Domsic, Robin Pokrzywinski, Larissa Stassek, Wade W Benton, Christa-Lynn Vampola, Daniel E Furst, Lorinda Chung, Virginia Steen, Maureen D Mayes, Ami A Shah, J...> ;ACR Open Rheumatology. 2023 Mar 1
Percutaneous revascularization for the treatment of refractory digital ischemia in systemic sclerosis.
Lily A Romero-Karam, Kevin A Honan, Salman A Arain, Maureen D Mayes> ;Journal of Scleroderma and Related Disorders. 2023 Feb 1
2 citations
STAT6 suppression prevents bleomycin-induced dermal fibrosis.
Jingjing Huang, Hydia Puente, Nancy E Wareing, Minghua Wu, Maureen D Mayes, Harry Karmouty-Quintana, Shervin Assassi, Tingting W Mills> ;FASEB Journal. 2023 Feb 1
1 citations
Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant.
Brian Skaug, Xinjian Guo, Yuanteng Jeff Li, Julio Charles, Kay T Pham, Jacob Couturier, Dorothy E Lewis, Claudia Bracaglia, Ivan Caiello, Maureen D Mayes, Shervin Assassi> ;Rheumatology. 2023 Sep 1
4 citations
Characterising the autoantibody repertoire in systemic sclerosis following myeloablative haematopoietic stem cell transplantation.
Burcu Ayoglu, Michele Donato, Daniel E Furst, Leslie J Crofford, Ellen Goldmuntz, Lynette Keyes-Elstein, Judith James, Susan Macwana, Maureen D Mayes, Peter McSweeney,...> ;Annals of the Rheumatic Diseases. 2023 May 1
24 citations
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
Franck F Rahaghi, Vivien M Hsu, Robert J Kaner, Maureen D Mayes, Ivan O Rosas, Rajan Saggar, Virginia D Steen, Mary E Strek, Elana J Bernstein, Nitin Bhatt, Flavia V C...> ;Respiratory Research. 2023 Jan 9
3 citations
Myeloablative autologous haematopoietic stem cell transplantation resets the B cell repertoire to a more naïve state in patients with systemic sclerosis.
Julia Z Adamska, Amin Zia, Michelle S Bloom, Leslie J Crofford, Daniel E Furst, Ellen Goldmuntz, Lynette Keyes-Elstein, Maureen D Mayes, Peter McSweeney, Richard A Nas...> ;Annals of the Rheumatic Diseases. 2023 Mar 1
2 citations
The Effect of Body Fat Distribution on Systemic Sclerosis.
Gonzalo Villanueva-Martin, Marialbert Acosta-Herrera, Martin Kerick, Elena López-Isac, Carmen P Simeón, José L Callejas, Shervin Assassi, Lorenzo Beretta, Internationa...> ;Journal of Clinical Medicine. 2022 Oct 12
4 citations
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis.
Martin Kerick, Marialbert Acosta-Herrera, Carmen Pilar Simeón-Aznar, José Luis Callejas, Shervin Assassi, , Susanna M Proudman, Mandana Nikpour, , , Nicolas Hunzelmann...> ;NPJ Genomic Medicine. 2022 Oct 5
14 citations
Continued treatment with nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from SENSCIS-ON.
Yannick Allanore, Madelon C Vonk, Oliver Distler, Arata Azuma, Maureen D Mayes, Martina Gahlemann, Alexandra James, Veronika Kohlbrenner, Margarida Alves, Dinesh Khann...> ;Annals of the Rheumatic Diseases. 2022 Dec 1
7 citations
Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial.
Dinesh Khanna, Paul Caldron, Richard W Martin, Suzanne Kafaja, Robert Spiera, Shadi Shahouri, Ankoor Shah, Vivien Hsu, John Ervin, Robert Simms, Robyn T Domsic, Virgin...> ;Arthritis & Rheumatology. 2022 Aug 1
Stem cell transplantation for systemic sclerosis.
Sebastian Bruera, Harish Sidanmat, Donald A Molony, Maureen D Mayes, Maria E Suarez-Almazor, Kate Krause, Maria Angeles Lopez-Olivo> ;The Cochrane Database of Systematic Reviews. 2022 Jul 29
Genetic Associations of Non-Major Histocompatibility Complex Susceptibility Loci with Systemic Sclerosis in a Han Chinese Population.
Weilin Pu, Rui Zhang, Yanyun Ma, Qingmei Liu, Shuai Jiang, Jing Liu, Yinhuan Zhao, Wenzhen Tu, Gang Guo, Xiaoxia Zuo, Qingwen Wang, Yuanyuan Chen, Wenyu Wu, Xiaodong Z...> ;The Journal of Investigative Dermatology. 2022 Jul 1
5 citations
False positive anti-Topoisomerase I (Scl-70) antibody results in clinical practice: A case series from a scleroderma referral center.
Brian H Lam, Shervin Assassi, Julio Charles, Marka A Lyons, Bochra Jandali, Maureen D Mayes, Brian Skaug, Taherian, R.> ;Seminars in Arthritis and Rheumatism. 2022 Oct 1
9 citations
47XXY and 47XXX in Scleroderma and Myositis.
R Hal Scofield, Valerie M Lewis, Joshua Cavitt, Biji T Kurien, Shervin Assassi, Javier Martin, Olga Gorlova, Peter Gregersen, Annette Lee, Lisa G Rider, Terrance O'Han...> ;ACR Open Rheumatology. 2022 Jun 1
10 citations
The Effect of Anti-Scl-70 Antibody Determination Method on Its Predictive Significance for Interstitial Lung Disease Progression in Systemic Sclerosis.
Bochra Jandali, Gloria A Salazar, Marie Hudson, Marvin J Fritzler, Marka A Lyons, Rosa M Estrada-Y-Martin, Julio Charles, Katherine A Terracina, Maureen D Mayes, Sherv...> ;ACR Open Rheumatology. 2022 Apr 1
11 citations
Large-scale analysis of longitudinal skin gene expression in systemic sclerosis reveals relationships of immune cell and fibroblast activity with skin thickness and a ...
Brian Skaug, Marka A Lyons, William R Swindell, Gloria A Salazar, Minghua Wu, Tuan M Tran, Julio Charles, Connor P Vershel, Maureen D Mayes, Shervin Assassi> ;Annals of the Rheumatic Diseases. 2022 Apr 1
6 citations
Blood Neutrophil Count and Neutrophil-to-Lymphocyte Ratio for Prediction of Disease Progression and Mortality in Two Independent Systemic Sclerosis Cohorts.
Nancy Wareing, Vishnu Mohan, Rana Taherian, Elizabeth R Volkmann, Marka A Lyons, Holly Wilhalme, Michael D Roth, Rosa M Estrada-Y-Martin, Brian Skaug, Maureen D Mayes,...> ;Arthritis Care & Research. 2023 Mar 1
2 citations
Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program.
Linda Kwakkenbos, Nora Østbø, Marie-Eve Carrier, Warren R Nielson, Claire Fedoruk, Brooke Levis, Richard S Henry, Janet Pope, Tracy Frech, Shadi Gholizadeh, Sindhu R J...> ;Pilot and Feasibility Studies. 2022 Feb 26
2 citations
Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy.
Ankoor Shah, Jan Storek, Rob Woolson, Ashley Pinckney, Lynnette Keyes-Elstein, Paul K Wallace, Gregory D Sempowski, Peter McSweeney, Maureen D Mayes, Leslie Crofford, ...> ;Rheumatology. 2022 Oct 6
1 citations
Total Percutaneous Revascularization of the Hand to Treat Refractory Digital Ischemia in Advanced Systemic Sclerosis.
Kevin A Honan, Lily Romero-Karam, Maureen Mayes, Salman A Arain> ;JACC. Case Reports. 2022 Feb 2
6 citations
Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes.
Aimee L Hanson, Joanne Sahhar, Gene-Siew Ngian, Janet Roddy, Jennifer Walker, Wendy Stevens, Mandana Nikpour, Shervin Assassi, Susanna Proudman, Maureen D Mayes, Tony ...> ;Frontiers in Genetics. 2022 Jan 1
Join now to see all

Journal Articles

The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma Cohorts
Daniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology